New drug trial aims to calm stomach inflammation
NCT ID NCT06317220
First seen Jan 08, 2026 · Last updated May 20, 2026 · Updated 16 times
Summary
This study tests whether vedolizumab, given through an IV, can reduce symptoms like belly pain, nausea, and bloating in people with collagenous gastritis. Eleven participants will receive the drug, complete symptom surveys, and have two endoscopies with biopsies. The goal is to see if symptoms improve and if the drug is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLLAGENOUS GASTRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.